enhanc renal excret dicloxacillin patient cystic fibrosi singl oral dose 625 mgkg dicloxacillin suspens given ten cystic fibrosi cf patient eight normal subject peak serum concentr area concentr versu time curv dicloxacillin variabl averag 2 12 time lower cf patient time occurr peak serum concentr similar group total urinari recoveri dicloxacillin normal increas cf patient suggest intestin absorpt drug unaffect diseas low serum concentr cf patient caus unusu high renal clearanc dicloxacillin averag 282 135 compar 95 28 mlmin173 sq normal subject creatinin clearanc also elev cf patient 55 averag urea clearanc normal serum protein bind dicloxacillin similar group subject rapid excret result low variabl serum concentr antibiot treatment cf patient dicloxacillin may warrant use increas frequent dose monitor serum antibiot level